Chemistry

pp.16 Date: May 30,1994 T.W. Ebbesen, P.M. Ajayan, "Large-scale synthesis of carbon nanotubes," Nature, 358:220-2, 1992. Thomas W. Ebbesen (Fundamental Research Laboratories, NEC Corp., Tsukuba, Japan): "Carbon nanotubes are very small, hollow graphitic tubes (nanometer in diameter, micrometer long) that generated a lot of excitement when they were first observed. They were seen both as elongated fullerenes and as the ultimate fib

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

pp.16
Date: May 30,1994

T.W. Ebbesen, P.M. Ajayan, "Large-scale synthesis of carbon nanotubes," Nature, 358:220-2, 1992.

Thomas W. Ebbesen (Fundamental Research Laboratories, NEC Corp., Tsukuba, Japan): "Carbon nanotubes are very small, hollow graphitic tubes (nanometer in diameter, micrometer long) that generated a lot of excitement when they were first observed. They were seen both as elongated fullerenes and as the ultimate fiber, since the hexagonal network of carbon atoms was perfect. Exciting properties were predicted for the nanotubes, but there was no way to verify them because the nanotubes were available in only minute quantities in a mixture of soot. That is probably why our paper on the large-scale synthesis of nanotubes has had a large impact. It opened the possibility for everyone to do experiments on nanotubes and verify their properties.

"It was while we were trying to make fullerene derivatives that we found that we had made large ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies